136 related articles for article (PubMed ID: 11511167)
1. Disproportionation of a model chromium(V) complex causes extensive chromium(III)-DNA binding in vitro.
Levina A; Lay PA; Dixon NE
Chem Res Toxicol; 2001 Aug; 14(8):946-50. PubMed ID: 11511167
[TBL] [Abstract][Full Text] [Related]
2. Disproportionation and nuclease activity of bis[2-ethyl-2-hydroxybutanoato(2-)]oxochromate(V) in neutral aqueous solutions.
Levina A; Lay PA; Dixon NE
Inorg Chem; 2000 Feb; 39(3):385-95. PubMed ID: 11229553
[TBL] [Abstract][Full Text] [Related]
3. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
[TBL] [Abstract][Full Text] [Related]
4. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
Zhitkovich A; Quievryn G; Messer J; Motylevich Z
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
[TBL] [Abstract][Full Text] [Related]
5. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
Zhitkovich A; Song Y; Quievryn G; Voitkun V
Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
[TBL] [Abstract][Full Text] [Related]
6. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
O'Brien T; Mandel HG; Pritchard DE; Patierno SR
Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic characterization of genotoxic chromium(V) peptide complexes: Oxidation of Chromium(III) triglycine, tetraglycine and pentaglycine complexes.
Headlam HA; Lay PA
J Inorg Biochem; 2016 Sep; 162():227-237. PubMed ID: 27365280
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis of lymphocytes induced by chromium(VI/V) is through ROS-mediated activation of Src-family kinases and caspase-3.
Vasant C; Rajaram R; Ramasami T
Free Radic Biol Med; 2003 Nov; 35(9):1082-100. PubMed ID: 14572611
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of ionic and coordinate covalent chromium (Cr)-DNA binding on DNA replication.
Fornsaglio JL; O'Brien TJ; Patierno SR
Mol Cell Biochem; 2005 Nov; 279(1-2):149-55. PubMed ID: 16283524
[TBL] [Abstract][Full Text] [Related]
11. Formation and reactivity of chromium(V)-thiolato complexes: a model for the intracellular reactions of carcinogenic chromium(VI) with biological thiols.
Levina A; Zhang L; Lay PA
J Am Chem Soc; 2010 Jun; 132(25):8720-31. PubMed ID: 20527748
[TBL] [Abstract][Full Text] [Related]
12. Chromium(VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro.
Stearns DM; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):21-5. PubMed ID: 7843100
[TBL] [Abstract][Full Text] [Related]
13. X-ray absorption spectroscopic studies of chromium(V/IV/III)- 2-ethyl-2-hydroxybutanoato(2-/1-) complexes.
Levina A; Codd R; Foran GJ; Hambley TW; Maschmeyer T; Masters AF; Lay PA
Inorg Chem; 2004 Feb; 43(3):1046-55. PubMed ID: 14753827
[TBL] [Abstract][Full Text] [Related]
14. Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: relevance to chromium genotoxicity.
Pattison DI; Davies MJ; Levina A; Dixon NE; Lay PA
Chem Res Toxicol; 2001 May; 14(5):500-10. PubMed ID: 11368547
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a chromium(V) cis-dioxo bis(1,10-phenanthroline) complex and crystal and molecular structures of its chromium(III) precursor.
Weeks CL; Levina A; Dillon CT; Turner P; Fenton RR; Lay PA
Inorg Chem; 2004 Nov; 43(24):7844-56. PubMed ID: 15554650
[TBL] [Abstract][Full Text] [Related]
16. Characterization of nonmutagenic Cr(III)-DNA interactions.
Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
[TBL] [Abstract][Full Text] [Related]
17. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
Zhitkovich A; Shrager S; Messer J
Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence for hydroxyl radical-induced damage to nucleic acids by chromium(VI)-derived species: implications for chromium carcinogenesis.
Molyneux MJ; Davies MJ
Carcinogenesis; 1995 Apr; 16(4):875-82. PubMed ID: 7537182
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization, and nuclease activity of biologically relevant chromium(V) complexes with monosaccharides and model diols. Likely intermediates in chromium-induced cancers.
Bartholomäus R; Irwin JA; Shi L; Smith SM; Levina A; Lay PA
Inorg Chem; 2013 Apr; 52(8):4282-92. PubMed ID: 23531300
[TBL] [Abstract][Full Text] [Related]
20. Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity.
Marchi S; Lankford E; Dorin B; Drummond E; Thomas SC; Woski SA; Vincent JB
Biol Trace Elem Res; 2023 Oct; 201(10):5053-5066. PubMed ID: 36662348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
